Reproductive endocrinology: Hormone therapy to treat menopause - Breaking a taboo

Research output: Contribution to journalLetterOther

Abstract

Findings from the Women?s Health Initiative hormone study send the message that clinicians can feel confident prescribing menopausal hormone replacement therapy (MHT) to young menopausal women with moderate-to-severe symptoms who do not have absolute contraindications for hormone therapy. However, MHT is indicated for the alleviation of symptoms, not for chronic disease prevention.
Original languageEnglish
Pages (from-to)6 - 8
Number of pages3
JournalNature Reviews Endocrinology
Volume10
Issue number1
DOIs
Publication statusPublished - 2014

Cite this

@article{0d6bb9b717864efba79f1317edd7c736,
title = "Reproductive endocrinology: Hormone therapy to treat menopause - Breaking a taboo",
abstract = "Findings from the Women?s Health Initiative hormone study send the message that clinicians can feel confident prescribing menopausal hormone replacement therapy (MHT) to young menopausal women with moderate-to-severe symptoms who do not have absolute contraindications for hormone therapy. However, MHT is indicated for the alleviation of symptoms, not for chronic disease prevention.",
author = "Davis, {Susan Ruth}",
year = "2014",
doi = "10.1038/nrendo.2013.219",
language = "English",
volume = "10",
pages = "6 -- 8",
journal = "Nature Reviews Endocrinology",
issn = "1759-5029",
publisher = "Nature Publishing Group",
number = "1",

}

Reproductive endocrinology: Hormone therapy to treat menopause - Breaking a taboo. / Davis, Susan Ruth.

In: Nature Reviews Endocrinology, Vol. 10, No. 1, 2014, p. 6 - 8.

Research output: Contribution to journalLetterOther

TY - JOUR

T1 - Reproductive endocrinology: Hormone therapy to treat menopause - Breaking a taboo

AU - Davis, Susan Ruth

PY - 2014

Y1 - 2014

N2 - Findings from the Women?s Health Initiative hormone study send the message that clinicians can feel confident prescribing menopausal hormone replacement therapy (MHT) to young menopausal women with moderate-to-severe symptoms who do not have absolute contraindications for hormone therapy. However, MHT is indicated for the alleviation of symptoms, not for chronic disease prevention.

AB - Findings from the Women?s Health Initiative hormone study send the message that clinicians can feel confident prescribing menopausal hormone replacement therapy (MHT) to young menopausal women with moderate-to-severe symptoms who do not have absolute contraindications for hormone therapy. However, MHT is indicated for the alleviation of symptoms, not for chronic disease prevention.

UR - http://www.nature.com/nrendo/journal/v10/n1/full/nrendo.2013.219.html

U2 - 10.1038/nrendo.2013.219

DO - 10.1038/nrendo.2013.219

M3 - Letter

VL - 10

SP - 6

EP - 8

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

SN - 1759-5029

IS - 1

ER -